Proactiveinvestors recommends

Additional Information

Market:	ASX
Sector:	Pharma & Biotech
EPIC:	POH
Latest Price:	0.20 (2.56% )
52-week High:	0.21
52-week Low:	0.10
Market Cap:	164.72M

1 year chart

1 day chart

Phosphagenics Limited

Phosphagenics (ASX: POH) is a Melbourne-based biotechnology company. Its core technology is built around the science and application of TPM™ delivery systems. This system enables transdermal delivery of proven pharmaceutical actives and enhances dermal delivery of pharmaceutical, cosmeceutical and nutraceutical actives.

Phosphagenics moving in leaps and bounds

Wednesday, March 17, 2010

Melbourne-based biotechnology company Phosphagenics (ASX: POH) has been quizzed by the Australian Securities Exchange noting an increase in market price from yesterday’s close of $0.071 and the volume of shares traded.

Current share price is $0.09.

The company indicated it was not aware of any information that had not been announced.

It said that in February 2010, a total of 157,960,969 shares were traded with six trading days recording volumes in excess of 10.7 million shares with the highest daily volumes being 43.3 million (01.02); 30.7 million (11.02) and 24.5 million (24.02).

In February 2010 the closing market prices ranged between $0.069 (01.02) and $0.08 (26.02) with the highest closing price being $0.099 (11.02).

The company made an announcement in relation to oxycodone on 1 February and then in the Appendix 4E on 19 February 2010, referring to the next oxycodone clinical trials being undertaken in the second half of 2010.

Phosphagenics' aim is to become the first company to offer an oxycodone patch that will provide sustained pain relief.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.